Evaluation of The Effect of Melatonin in Thrombocytopenia

Evaluation of The Effect of Melatonin in Chemotherapy Induced Thrombocytopenia in Cancerous Patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20080901001165N41

Enrollment

100

Registered

2019-10-31

Start date

2019-11-11

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombocytopenia. Thrombocytopenia, unspecified

Interventions

Intervention 1: Intervention group: Patients Will Receive 10 mg of Melatonin Every Night for 12 Weeks. Intervention 2: Control group: Patients Will Receive 10 mg of Placebo (Without Melatonin) Once Da

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Blood Platelets is less than 100,000 Per Microliter of Blood. To sign the consent form knowingly. At the same time,not in another clinical study. The patient is between 18-65 years old.

Exclusion criteria

Exclusion criteria: The Patient is Pregnant.

Design outcomes

Primary

Measure	Time frame
Blood Platelet Count (Per Microliter of Blood). Timepoint: Before The Intervention and then Weekly for 12 Weeks. Method of measurement: Cell Blood Counter (CBC).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Firouzeie

Bagheiat-allah University of Medical Sciences

amirfirouzeie@gmail.com+98 21 2264 0051

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026